Cargando…
Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study
PURPOSE: To summarize and discuss the treatment and timing of glaucoma in patients with MICOF keratoprosthesis implantation to guide follow-up clinical treatment. METHODS: The data of 39 eyes (39 patients) with the Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis implantation in ou...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562139/ https://www.ncbi.nlm.nih.gov/pubmed/36250075 http://dx.doi.org/10.3389/fmed.2022.986176 |
_version_ | 1784808102492635136 |
---|---|
author | Li, Zhao Wang, Qun Zhang, Shi-Feng Huang, Yi-Fei Wang, Li-Qiang |
author_facet | Li, Zhao Wang, Qun Zhang, Shi-Feng Huang, Yi-Fei Wang, Li-Qiang |
author_sort | Li, Zhao |
collection | PubMed |
description | PURPOSE: To summarize and discuss the treatment and timing of glaucoma in patients with MICOF keratoprosthesis implantation to guide follow-up clinical treatment. METHODS: The data of 39 eyes (39 patients) with the Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis implantation in our hospital from 1 January 2002 to 31 December 2017 were collected, including patients with preexisting glaucoma and those who developed glaucoma de novo after MICOF. The sex, age, preoperative diagnosis, glaucoma surgery, keratoplasty, times of keratoplasty, best corrected visual acuity (BCVA) and final follow-up corrected visual acuity, visual field (VF) defect, and cup-to-disk ratio (CDR) were statistically analyzed. RESULTS: Among 16 eyes with preexisting glaucoma, eight eyes underwent glaucoma surgery before MICOF, 4 eyes underwent glaucoma surgery combined with MICOF, and four eyes were managed medically. Among 23 eyes with de novo glaucoma, seven eyes were treated with surgery and 16 eyes were treated with medication only. A total of 9 (56.3%) eyes had corneal transplants with preexisting glaucoma, which was a higher percentage than that in the patients with de novo glaucoma (n = 5, 21.7%, P = 0.043). In both the preexisting glaucoma group and the de novo glaucoma group, the most common causes were alkali burns (56.3% of preexisting glaucoma and 43.5% of de novo glaucoma). There was no significant difference between the operation and initial visual acuity, postoperative visual acuity, BCVA, CDR, or VF defect. In the de novo glaucoma group, the final follow-up visual acuity of the glaucoma surgery group (1.56 ± 1.07) was worse than that of the mediation group (0.44 ± 0.53) (P < 0.017). Among the complications, the incidence of cornea melting in the patients treated with medications only (n=10) was significantly higher than that in the patients treated with glaucoma surgery (n = 0, P = 0.007), but there was no significant difference in the other complications. CONCLUSION: Among patients with MICOF, those patients who have undergone keratoplasty are more likely to develop glaucoma before surgery and glaucoma needs to be prevented. Surgical treatment can be selected according to the ocular surface condition in the patients with de novo glaucoma to reduce the occurrence of complications. |
format | Online Article Text |
id | pubmed-9562139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95621392022-10-15 Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study Li, Zhao Wang, Qun Zhang, Shi-Feng Huang, Yi-Fei Wang, Li-Qiang Front Med (Lausanne) Medicine PURPOSE: To summarize and discuss the treatment and timing of glaucoma in patients with MICOF keratoprosthesis implantation to guide follow-up clinical treatment. METHODS: The data of 39 eyes (39 patients) with the Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis implantation in our hospital from 1 January 2002 to 31 December 2017 were collected, including patients with preexisting glaucoma and those who developed glaucoma de novo after MICOF. The sex, age, preoperative diagnosis, glaucoma surgery, keratoplasty, times of keratoplasty, best corrected visual acuity (BCVA) and final follow-up corrected visual acuity, visual field (VF) defect, and cup-to-disk ratio (CDR) were statistically analyzed. RESULTS: Among 16 eyes with preexisting glaucoma, eight eyes underwent glaucoma surgery before MICOF, 4 eyes underwent glaucoma surgery combined with MICOF, and four eyes were managed medically. Among 23 eyes with de novo glaucoma, seven eyes were treated with surgery and 16 eyes were treated with medication only. A total of 9 (56.3%) eyes had corneal transplants with preexisting glaucoma, which was a higher percentage than that in the patients with de novo glaucoma (n = 5, 21.7%, P = 0.043). In both the preexisting glaucoma group and the de novo glaucoma group, the most common causes were alkali burns (56.3% of preexisting glaucoma and 43.5% of de novo glaucoma). There was no significant difference between the operation and initial visual acuity, postoperative visual acuity, BCVA, CDR, or VF defect. In the de novo glaucoma group, the final follow-up visual acuity of the glaucoma surgery group (1.56 ± 1.07) was worse than that of the mediation group (0.44 ± 0.53) (P < 0.017). Among the complications, the incidence of cornea melting in the patients treated with medications only (n=10) was significantly higher than that in the patients treated with glaucoma surgery (n = 0, P = 0.007), but there was no significant difference in the other complications. CONCLUSION: Among patients with MICOF, those patients who have undergone keratoplasty are more likely to develop glaucoma before surgery and glaucoma needs to be prevented. Surgical treatment can be selected according to the ocular surface condition in the patients with de novo glaucoma to reduce the occurrence of complications. Frontiers Media S.A. 2022-09-29 /pmc/articles/PMC9562139/ /pubmed/36250075 http://dx.doi.org/10.3389/fmed.2022.986176 Text en Copyright © 2022 Li, Wang, Zhang, Huang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Li, Zhao Wang, Qun Zhang, Shi-Feng Huang, Yi-Fei Wang, Li-Qiang Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study |
title | Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study |
title_full | Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study |
title_fullStr | Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study |
title_full_unstemmed | Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study |
title_short | Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study |
title_sort | timing of glaucoma treatment in patients with micof: a retrospective clinical study |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562139/ https://www.ncbi.nlm.nih.gov/pubmed/36250075 http://dx.doi.org/10.3389/fmed.2022.986176 |
work_keys_str_mv | AT lizhao timingofglaucomatreatmentinpatientswithmicofaretrospectiveclinicalstudy AT wangqun timingofglaucomatreatmentinpatientswithmicofaretrospectiveclinicalstudy AT zhangshifeng timingofglaucomatreatmentinpatientswithmicofaretrospectiveclinicalstudy AT huangyifei timingofglaucomatreatmentinpatientswithmicofaretrospectiveclinicalstudy AT wangliqiang timingofglaucomatreatmentinpatientswithmicofaretrospectiveclinicalstudy |